Artiva Biotherapeutics revenue was $251.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARTV annual revenue was $251.0k, with -99.3% growth year-over-year.
ARTV past revenue growth
How has ARTV's revenue growth performed historically?
Artiva Biotherapeutics (NASDAQ: ARTV) reported Q4 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Artiva Biotherapeutics's revenue was $2.35 million.
What was Artiva Biotherapeutics's revenue in 2024?
Artiva Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $251.00 thousand, a 99.25% decrease year over year.
How much does Artiva Biotherapeutics make in a day?
Based on Artiva Biotherapeutics annual revenue for the past two years, ARTV makes an average of $46,223.29 per day.
What was Artiva Biotherapeutics's annual revenue growth in the past year?
As of Q2 2025, Artiva Biotherapeutics's revenue has grown -99.25% year over year. This is 596.94 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Artiva Biotherapeutics's revenue in the past year totaled $251.00 thousand.
How much does Artiva Biotherapeutics make in a year?
Artiva Biotherapeutics's revenue by year for the past two years is:
Artiva Biotherapeutics's revenue for the twelve months ending Dec 31, 2024 was $251.00 thousand, a 99.25% decrease year over year.
Artiva Biotherapeutics's annual revenue for Dec 31, 2023 was $33.49 million, a 579.21% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.